Abstract:There are limited epidemiologic studies describing the global burden and geographic heterogeneity of interstitial lung disease (ILD) subtypes. We found that among seventeen methodologically heterogenous studies that examined the incidence, prevalence and relative frequencies of ILDs, the incidence of ILD ranged from 1 to 31.5 per 100,000 person-years and prevalence ranged from 6.3 to 71 per 100,000 people. In North America and Europe, idiopathic pulmonary fibrosis and sarcoidosis were the most prevalent ILDs while the relative frequency of hypersensitivity pneumonitis was higher in Asia, particularly in India (10.7–47.3%) and Pakistan (12.6%). The relative frequency of connective tissue disease ILD demonstrated the greatest geographic variability, ranging from 7.5% of cases in Belgium to 33.3% of cases in Canada and 34.8% of cases in Saudi Arabia. These differences may represent true differences based on underlying characteristics of the source populations or methodological differences in disease classification and patient recruitment (registry vs. population-based cohorts). There are three areas where we feel addition work is needed to better understand the global burden of ILD. First, a standard ontology with diagnostic confidence thresholds for comparative epidemiology studies of ILD is needed. Second, more globally representative data should be published in English language journals as current literature has largely focused on Europe and North America with little data from South America, Africa and Asia. Third, the inclusion of community-based cohorts that leverage the strength of large databases can help better estimate population burden of disease. These large, community-based longitudinal cohorts would also allow for tracking of global trends and be a valuable resource for collective study. We believe the ILD research community should organize to define a shared ontology for disease classification and commit to conducting global claims and electronic health record based epidemiologic studies in a standardized fashion. Aggregating and sharing this type of data would provide a unique opportunity for international collaboration as our understanding of ILD continues to grow and evolve. Better understanding the geographic and temporal patterns of disease prevalence and identifying clusters of ILD subtypes will facilitate improved understanding of emerging risk factors and help identify targets for future intervention.

The far reaching implications of Interstitial Lung Diseases Delayed Diagnosis

Risk factors for diagnostic delay in idiopathic pulmonary fibrosis

A Practical Multidisciplinary Approach to Identifying Interstitial Lung Disease in Systemic Autoimmune Rheumatic Diseases: A Clinician's Narrative Review

Variability in Global Prevalence of Interstitial Lung Disease

Purification of allantoicase fromPseudomonas aeruginosa

Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry

Interstitial lung diseases: never forget to think about it in primary care

Interstitial lung abnormalities: What do we know and how do we manage?

Risk Factors for Hospital Readmission in Patients with Interstitial Lung Disease

Characterisation of incident interstitial lung disease in late systemic sclerosis

Interstitial lung disease: a review of classification, etiology, epidemiology, clinical diagnosis, pharmacological and non-pharmacological treatment

Aerosol delivery in interstitial lung diseases - breakthrough or lost cause?

Hospitalisation patterns in interstitial lung diseases: data from the EXCITING-ILD registry

[Interstitial lung diseases : From imaging to treatment]

Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?

Interstitial Lung Abnormality: Narrative Review of the Approach to Diagnosis and Management

STUDY ON CLINICO-RADIOLOGICAL FEATURES INDICATIVE OF INTERSTITIAL LUNG DISEASE WITH THE HELP OF SPIROMETRY, CHEST X-RAY AND HIGH RESOLUTION COMPUTED TOMOGRAPHY CHEST

Complications of fibrotic interstitial lung disease for the general radiologist

Practical guidance for the early recognition and follow-up of patients with connective tissue disease-related interstitial lung disease

Interstitial Lung Disease as an emerging contributor to mortality in patients with Inflammatory Bowel Disease: A population-based epidemiological study

Interdisciplinary Diagnosis and Management of Patients With Interstitial Lung Disease and Connective Tissue Disease